Search
for
Sort by
Research 91–120 of 1000+
- Finasteride use in the male infertility population: effects on semen and hormone parameters
- Treatment with and withdrawal from finasteride alter ethanol intake patterns in male C57BL/6J mice: Potential role of endogenous neurosteroids?
- Chitosan-decorated polystyrene-b-poly(acrylic acid) polymersomes as novel carriers for topical delivery of finasteride
- A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
- Comparitive Effectiveness and Finasteride <i>Vs Serenoa Repens</i> in Male Androgenetic Alopecia: A Two-Year Study
- Finasteride for female androgenetic alopecia
- Comparison of high-dose finasteride (5 mg/day) versus low-dose finasteride (2.5 mg/day) in the treatment of hirsutism
- Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
- Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss
- A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers
- A prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism
- Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism
- Finasteride as a therapy for hidradenitis suppurativa
- Finasteride in the treatment of hirsutism: new therapeutic perspectives
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- Intraoperative floppy-iris syndrome and finasteride intake
- The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- Tamoxifen for flutamide/finasteride-induced gynecomastia
- Design of Finasteride-Loaded Nanoparticles for Potential Treatment of Alopecia
- Finasteride, a 5alpha-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice.
- Enhanced Topical Delivery of Finasteride Using Glyceryl Monooleate-Based Liquid Crystalline Nanoparticles Stabilized by Cremophor Surfactants
- Inhibition of Human Steroid 5β-Reductase (AKR1D1) by Finasteride and Structure of the Enzyme-Inhibitor Complex
- A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism
- Progesterone enhances ethanol-induced modulation of mesocortical dopamine neurons: antagonism by finasteride
- A preliminary study of finasteride in Tourette syndrome
- Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss
- Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride
- Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride
- Picogram determination of finasteride in human plasma and semen by high-performance liquid chromatography with atmospheric-pressure chemical-ionization tandem mass spectrometry